The Asia Pacific BNP and NT-proBNP Market would witness market growth of 12.4% CAGR during the forecast period (2022-2028).
Natriuresis, vasodilatation, and diuresis are the major effects of BNP. The natriuretic peptide receptor C (NPR-C), responsible for regulating receptor-mediated lysosomal and endocytosis degradation, binds to BNP and clears it from the body. Neutral endopeptidases, which are found in cells present in the vascular walls and renal tubular cells, also break down BNP. NTproBNP, a substance with a half-life of about 120 minutes compared to 20 minutes for BNP, is considered to be excreted by the kidney.
Although NT-proBNP is eliminated in a 1:1 ratio to BNP, the differences in half-lives and clearance processes account for the significantly larger amounts of NT-proBNP in serum. BNP and NT-proBNP levels have been demonstrated to correlate favorably with echocardiographic abnormalities in CKD patients. Both ventricular dysfunction/hypertrophy and volume overload have been implicated in increased BNP and NT-proBNP in dialysis patients.
Asia Pacific is anticipated to grow significantly during the forecast period. Government funding for specific diagnosis and other research has increased due to the rising incidence of CVDs (cardiovascular diseases). In comparison to other developing nations of the region, India has a considerable prevalence of CVDs. The high prevalence of the disease has facilitated a rise in the need for bnp and ntprobnp diagnostics to aid in the early detection, assessment, and treatment of CVDs. Throughout the forecast period, the bnp and ntprobnp market in the Asia Pacific region is expanding significantly.
The China market dominated the Asia Pacific BNP and NT-proBNP Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $181.3 Million by 2028. The Japan market is estimated to grow a CAGR of 11.7% during (2022 - 2028). Additionally, The India market would experience a CAGR of 13.1% during (2022 - 2028).
Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on Application, the market is segmented into Myocardial Infarction, Acute Coronary Syndrome (ACS), Congestive Heart Failure (CHF) and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide BNP and NT-proBNP Market is Projected to reach USD 2.2 Billion by 2028, at a CAGR of 11.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Siemens AG, Danaher Corporation, Gentian Diagnostics ASA, PerkinElmer, Inc., BioMérieux S.A., Quidel Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.), and Scripps Laboratories.
Scope of the Study
Market Segments Covered in the Report:
By Location of Testing
- Point of Care Testing
- Laboratory Testing
By Application
- Myocardial Infarction
- Acute Coronary Syndrome (ACS)
- Congestive Heart Failure (CHF)
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Siemens AG
- Danaher Corporation
- Gentian Diagnostics ASA
- PerkinElmer, Inc.
- BioMérieux S.A.
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- F.Hoffmann-La Roche Ltd. (Roche Holding Ltd.)
- Scripps Laboratories
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific BNP and NT-proBNP Market, by Location of Testing
1.4.2 Asia Pacific BNP and NT-proBNP Market, by Application
1.4.3 Asia Pacific BNP and NT-proBNP Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific BNP and NT-proBNP Market by Location of Testing
3.1 Asia Pacific Point of Care Testing Market by Country
3.2 Asia Pacific Laboratory Testing Market by Country
Chapter 4. Asia Pacific BNP and NT-proBNP Market by Application
4.1 Asia Pacific Myocardial Infarction Market by Country
4.2 Asia Pacific Acute Coronary Syndrome (ACS) Market by Country
4.3 Asia Pacific Congestive Heart Failure (CHF) Market by Country
4.4 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific BNP and NT-proBNP Market by Country
5.1 China BNP and NT-proBNP Market
5.1.1 China BNP and NT-proBNP Market by Location of Testing
5.1.2 China BNP and NT-proBNP Market by Application
5.2 Japan BNP and NT-proBNP Market
5.2.1 Japan BNP and NT-proBNP Market by Location of Testing
5.2.2 Japan BNP and NT-proBNP Market by Application
5.3 India BNP and NT-proBNP Market
5.3.1 India BNP and NT-proBNP Market by Location of Testing
5.3.2 India BNP and NT-proBNP Market by Application
5.4 South Korea BNP and NT-proBNP Market
5.4.1 South Korea BNP and NT-proBNP Market by Location of Testing
5.4.2 South Korea BNP and NT-proBNP Market by Application
5.5 Singapore BNP and NT-proBNP Market
5.5.1 Singapore BNP and NT-proBNP Market by Location of Testing
5.5.2 Singapore BNP and NT-proBNP Market by Application
5.6 Malaysia BNP and NT-proBNP Market
5.6.1 Malaysia BNP and NT-proBNP Market by Location of Testing
5.6.2 Malaysia BNP and NT-proBNP Market by Application
5.7 Rest of Asia Pacific BNP and NT-proBNP Market
5.7.1 Rest of Asia Pacific BNP and NT-proBNP Market by Location of Testing
5.7.2 Rest of Asia Pacific BNP and NT-proBNP Market by Application
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 Siemens AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 SWOT Analysis
6.3 Danaher Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Gentian Diagnostics ASA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 PerkinElmer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 BioMérieux S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Quidel Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Bio-Rad laboratories, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.10. Scripps Laboratories
6.10.1 Company Overview
TABLE 1 Asia Pacific BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 4 Asia Pacific BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Point of Care Testing Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Point of Care Testing Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Laboratory Testing Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Laboratory Testing Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 10 Asia Pacific BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Acute Coronary Syndrome (ACS) Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Acute Coronary Syndrome (ACS) Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Congestive Heart Failure (CHF) Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Congestive Heart Failure (CHF) Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific BNP and NT-proBNP Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific BNP and NT-proBNP Market by Country, 2022 - 2028, USD Million
TABLE 21 China BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 22 China BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 23 China BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 24 China BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 25 China BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 26 China BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 27 Japan BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 28 Japan BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 29 Japan BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 30 Japan BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 31 Japan BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 32 Japan BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 33 India BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 34 India BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 35 India BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 36 India BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 37 India BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 38 India BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 39 South Korea BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 40 South Korea BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 41 South Korea BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 42 South Korea BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 43 South Korea BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 44 South Korea BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 45 Singapore BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 46 Singapore BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 47 Singapore BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 48 Singapore BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 49 Singapore BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 50 Singapore BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 51 Malaysia BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 52 Malaysia BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 53 Malaysia BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 54 Malaysia BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 55 Malaysia BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 56 Malaysia BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 57 Rest of Asia Pacific BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 58 Rest of Asia Pacific BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 59 Rest of Asia Pacific BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 60 Rest of Asia Pacific BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 61 Rest of Asia Pacific BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 62 Rest of Asia Pacific BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 63 Key Information – Abbott Laboratories
TABLE 64 Key Information – Siemens AG
TABLE 65 Key Information – Danaher Corporation
TABLE 66 Key Information – Gentian Diagnostics ASA
TABLE 67 key Information – PerkinElmer, Inc.
TABLE 68 Key information – BioMérieux S.A.
TABLE 69 key information – Quidel Corporation
TABLE 70 Key Information – Bio-Rad Laboratories, Inc.
TABLE 71 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 72 Key Information – Scripps Laboratories
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories
FIG 3 Swot analysis: Siemens AG